Karuna Therapeutics, Inc. Common Stock
KRTX
KRTX was delisted on the 15th of March, 2024.
143 hedge funds and large institutions have $2.19B invested in Karuna Therapeutics, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 48 increasing their positions, 46 reducing their positions, and 16 closing their positions.
135% more call options, than puts
Call options by funds: $17.2M | Put options by funds: $7.32M
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
69% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 16
40% more capital invested
Capital invested by funds: $1.56B → $2.19B (+$629M)
8% more funds holding
Funds holding: 132 → 143 (+11)
4% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 46
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$62.2M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$17.2M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$12.3M |
| 4 |
Holocene Advisors
New York
|
+$12.1M |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
+$11.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity International
Hamilton,
Bermuda
|
-$62.2M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
-$30.2M |
| 3 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$10.7M |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$10M |
| 5 |
Capital International Investors
Los Angeles,
California
|
-$8.46M |
KRTX Hedge Fund Activity: Q4 2020 in Review
143 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Karuna Therapeutics, Inc. Common Stock (KRTX) for Q4 2020, worth a combined $2.19B — up 40% from $1.56B a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new KRTX positions and 16 closed out — a net gain of 11 holders — while 48 added to existing stakes and 46 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $62.2M. The largest seller was Fidelity International, cutting an estimated $62.2M.
- 143 institutional investors held Karuna Therapeutics, Inc. Common Stock (KRTX) as of Q4 2020, up from 132 in Q3 2020.
- Funds reported $2.19B of Karuna Therapeutics, Inc. Common Stock stock for Q4 2020, up 40% quarter-over-quarter.
- 27 funds opened new Karuna Therapeutics, Inc. Common Stock positions in Q4 2020 and 16 closed out, a net change of +11 holders.
- The largest Karuna Therapeutics, Inc. Common Stock buyer in Q4 2020 was Fidelity Investments, an estimated $62.2M added.
- The largest Karuna Therapeutics, Inc. Common Stock seller in Q4 2020 was Fidelity International, an estimated $62.2M sold.
Based on aggregated 13F filings for Q4 2020.